SamanthaZullowMD

PubMed

• Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission.
  Lauren A George, Harris T Feldman, Madeline Alizadeh, Ameer Abutaleb, Samantha Zullow, Ashley Hine, Kristen Stashek, Suparna Sarkar, Katherine Sun, David Hudesman, Jor...> ;Crohn's & Colitis 360. 2023 Oct 1
• 15 citations
  Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States.
  Simon J Hong, Noa Krugliak Cleveland, Shintaro Akiyama, Samantha Zullow, Yangtian Yi, Seth R Shaffer, Lisa B Malter, Jordan E Axelrad, Shannon Chang, David P Hudesman,...> ;Crohn's & Colitis 360. 2021 Jan 1
• 1 citations
  Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy.
  William T. Clarke, Venkata R. Satyam, David I. Fudman, Samantha Zullow, Kashika G. Goyal, Katerina L. Byanova, Christopher S. Huang, Joseph D. Feuerstein> ;Gastroenterology Report. 2020 Oct 1
• 1 citations
  Eosinophilic esophagitis, gastroenteritis, and colitis in a patient with prior parasite exposure.
  Robert M. Wilechansky, Matthew Spring, Qin Huang, Samantha Zullow> ;Clinical Journal of Gastroenterology. 2019 May 10
• 11 citations
  Updates on vaccinating the inflammatory bowel disease patient.
  Samantha Zullow, Francis A. Farraye> ;Expert Review of Gastroenterology & Hepatology. 2019 Jan 21
• Gastrointestinal cancers in patients with cystic fibrosis - Authors' reply.
  Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Dejan Micic, Samantha Zullow, Atsushi Sakuraba> ;The Lancet. Oncology. 2018 Aug 1
• Gastrointestinal cancer risk in cystic fibrosis: more exploration is needed - Authors' reply
  Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Dejan Micic, Samantha Zullow, Atsushi Sakuraba> ;The Lancet. Oncology. 2018 Jun 29
• 98 citations
  Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.
  Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Dejan Micic, Samantha Zullow, Atsushi Sakuraba> ;The Lancet. Oncology. 2018 Jun 1
• Reply.
  Samantha Zullow, Sharmeel K Wasan, Bhavesh Shah, Francis A Farraye> ;Inflammatory Bowel Diseases. 2016 Nov 1
• 15 citations
  Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population
  Samantha Zullow, Guruprasad Jambaulikar, Ankur Rustgi, Sandra M. Quezada, Raymond K. Cross> ;Digestive Diseases and Sciences. 2017 May 25
• 1 citations
  Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC
  Samantha Zullow, Ahad Fazelat, Francis A. Farraye> ;Inflammatory Bowel Diseases. 2017 May 1
• 27 citations
  Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.
  Sharmeel K. Wasan, Samantha Zullow, Adam M. Berg, Adam S. Cheifetz, Lisa Ganley-Leal, Francis A. Farraye> ;Inflammatory Bowel Diseases. 2016 Jun 1
• 2 citations
  A Health Survey of Gastroenterologist Prescribing Practices of Adalimumab for Treatment of Crohn's Disease: Final Results.
  Samantha Zullow, Mark Flasar, Deborah Greenberg, J. Kathleen Tracy, Ankur Rustgi, Raymond K. Cross> ;Gastroenterology & Hepatology. 2014 Aug 1
• Join now to see all

Abstracts/Posters

• Histologic Inflammation Defined by the Robarts Histopathologic Index may Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
  George L, Feldman H, Hine AM, Zullow S, Stashek KM, Sun K, Suparna SA. Sarkar, Abutaleb A, Hudesman D, Axelrad JE, Cross RK, Digestive Disease Week 2020, Cancelled due to COVID Pandemic, 5/1/2020
• The Real-World Effectiveness of Ustekinumab in Ulcerative Colitis
  Hong S, Zullow S, Axelrad JE, Chang S, Hudesman D, Crohn's & Colitis Congress, Austin, Texas, 2/1/2020
• Mild Endoscopic Activity Is Associated With an Increased Risk of Relapse in Patients With Ulcerative Colitis
  Feldman, H, George L, Abutaleb A, Hine AM, Zullow S, Axelrad JE, Hudesman D, Cross RK, American College of Gastroenterology, San Antonio, Texas, 10/23/2019
• Effectiveness and Safety of Ustekinumab for Crohn’s Disease in Routine Clinical Practice
  Lynn AM, Barsky M, Ahmed W, Zullow S, Jairath V, Kochhar G, Weiss A, Phipps M, Agrawal M, Click BH, Meserve J, Swaminath A, Bohm M, Sagi S, Fischer M, Chang S, Lawlor..., Digestive Disease Week 2019, San Diego, 5/2019
• Efficacy of Ustekinumab in Patients with Refractory Perianal Crohn’s Disease in a Tertiary Care Population
  Satyam V, Zullow S, Noronha A, Wasan SK, Farraye FA, Digestive Disease Week 2018, Washington DC, 6/2018
• Case Series: Ustekinumab Use in Metastatic Cutaneous Crohn's Disease
  Zullow S, Lichtman MK, Larson A, Stier E, Farraye FA, American College of Gastroenterology, Orlando, FL, 10/2017
• When the Rules Don't Apply: Anticoagulation in Patients with Infective Endocarditis and Embolic Stroke
  Harvey L, Ohm J, Zullow S, Schembri F, Society of General Internal Medicine
• Risk of Gastrointestinal Cancers in Cystic Fibrosis: A Systematic Review and Meta-Analysis
  Zullow S, Sakuraba A, Digestive Disease Week, 5/2015
• A Health Survey of Gastroenterologist Prescribing Practices with Adalimumab for Crohn's Disease
  Zullow S, Greenberg D, Tracy K, Rustgi A, Cross R, Flasar M, Advances in Inflammatory Bowel Diseases, Hollywood, FL, 12/2012
• Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population
  Zullow S, Rustgi A, Quezada S, Cross RK, Digestive Disease Week, 5/2012
• The Role of Histamine 4 Receptor in the Pathogenesis of Crohn's Disease
  Zullow S, Mayer L, SURP Fellows, Mount Sinai, New York, NY, 8/2008
• Join now to see all